ORICOric Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Oric Pharmaceuticals, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORICThis | $1.3B#8 | — | 3.4x#3 | — | — | -1.3%#6 | — | -34.0%#6 | -40.4%#3 | — | 15.1%#2 | — |
| DMRA | $1.5B#1 | 3.2x#2 | 2.9x#1 | — | — | -878.8%#10 | — | -40.7%#7 | — | — | — | — |
| BCAX | $1.5B#2 | — | 3.1x#2 | — | — | -102.9%#8 | — | -29.4%#3 | — | — | 95.6%#1 | — |
| TYRA | $1.5B#3 | — | 4.1x#5 | — | — | -38.7%#7 | — | -33.9%#5 | — | — | — | — |
| XERS | $1.4B#4 | — | — | 4.9x#3 | 43.7%#1 | 101.0%#1 | 8.5%#2 | — | 20.6%#1 | — | 4.4%#3 | — |
| TRAX | $1.4B#5 | — | 8.3x#7 | — | — | — | — | 0.0%#1 | — | — | — | — |
| LBRX | $1.4B#6 | 1.9x#1 | 4.1x#6 | — | — | 60.1%#4 | — | -7.6%#2 | — | — | — | — |
| AVBP | $1.4B#7 | — | 3.7x#4 | — | — | -106.6%#9 | — | -45.3%#8 | — | — | — | — |
| HROW | $1.3B#9 | — | 84.4x#8 | 4.7x#2 | 36.4%#2 | 70.6%#3 | 11.2%#1 | -33.8%#4 | 13.2%#2 | 6#1 | — | — |
| RARE | $1.3B#10 | — | — | 1.9x#1 | 20.2%#3 | -1.1%#5 | -79.5%#3 | — | — | — | — | — |
| OMER | $1.3B#11 | 10.0x#3 | — | 17.0x#4 | -34.0%#4 | 97.9%#2 | -166.4%#4 | — | -151.8%#4 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice